Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements (French, HTML)

View metadata and access the original French HTML file: Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-29

The only amendment related to post-market regulation is the Minister’s new (continued) authority to impose terms and conditions for a designated COVID-19 drug (C.01.014.21).

Access original file